Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Citi downgrades Man Group on 'significant performance earnings risks'

(Sharecast News) - Citi downgraded Man Group on Wednesday to 'neutral' from 'buy' and slashed the price target to 185p from 265p on "significant performance earnings risks". It noted the shares have fallen around 20% year-to-date, notably underperforming Citi's European Diversified Financials coverage up 5%.

"While we are constructive on the group's medium-term growth outlook, we are concerned that recent weak performance of key (high-margin) AHL strategies could continue, potentially resulting in both outflows but also weak performance fee generation," Citi said.

"Indeed, we do not expect key AHL strategies to generate performance fees until 2027, resulting in Citi estimates circa 20% below consensus over FY25-27."

Citi said the stock's valuation is not demanding and offers significant optionality to any recovery in performance, but with significant downside risk to consensus estimates, it sees "less pressing need for investors to own the shares now", hence the downgrade.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.